FOSTER CITY, Calif. & OSS, The Netherlands--(BUSINESS WIRE)--Entelos, Inc. (LSE:ENTL) a leading life sciences company building predictive computer models of human physiology and “virtual patients” for drug discovery and development and Organon, the human healthcare business unit of Akzo Nobel (NASDAQ:AKZOY), announced today a two-year extension of their ongoing rheumatoid arthritis (RA) collaboration. Financial terms were not disclosed.
